section name header

Basic Information

AUTHORS: Nathan Stanford, MD and Alan Taylor, MD

Definition

Chalazion is one of the most common, usually noninfectious inflammatory lesions of the eyelid, accounting for approximately 13% of all benign eyelid lesions. These lesions typically present as localized areas of painless swelling and feel like a rubbery nodule to palpation.1 Diagnosis is based on clinical appearance. Chalazia are formed due to a granulomatous inflammatory reaction secondary to leakage of the lipid content of an obstructed Zeis or meibomian gland into the surrounding tarsal plate. While it is possible that an infection can cause the obstruction that leads to chalazion, the chalazion itself is an inflammatory reaction. This results in a sterile, painless lesion, which grows over weeks to months. These can eventually become infected and painful if not treated.

Synonyms

Meibomian gland lipogranuloma

Sebaceous cyst

Meibomian cyst

ICD-10CM CODES
H00.1 Chalazion
H00.11 Right upper eyelid
H00.12 Right lower eyelid
H00.13 Right eye, unspecified eyelid
H00.14 Left upper eyelid
H00.15 Left lower eyelid
H00.16 Left eye, unspecified eyelid
H00.19 Unspecified eye, unspecified eyelid
Epidemiology & Demographics
Incidence

Common condition, exact incidence not known

Prevalence

Unknown

Predominant Sex & Age

Affects males and females equally, more common in adults 30 to 50 yr old

Peak Incidence

Most common in adults ages 30 to 50

Risk Factors

  • Prior chalazion
  • Recent conjunctivitis or poor lid hygiene
  • Acne rosacea
  • Chronic blepharitis
  • Vitamin A deficiency
  • With the 2020 COVID-19 pandemic, facemask use has been shown to be a risk factor for chalazion formation2
Genetics

Not applicable

Physical Findings & Clinical Presentation

  • Painless localized nodule on the eyelid (Fig. E1).
  • Lesion will be firm and rubbery.
  • Possible impaired vision depending on size of lesion.
  • Increased swelling for weeks or months.
  • Can become inflamed, painful, or infected.
  • Can be visualized on the external eyelid or internal eyelid.
  • Duration usually longer than 2 wk compared to styes, which usually have a shorter course.3
  • Typically, benign and self-limited lesion. If persistent or recurrent, a chalazion should be evaluated for malignancy.

Figure E1 Chalazion

A, Histopathology Shows a Lipogranuloma; the Large Pale Cells are Epithelioid Cells and the Well-Demarcated Empty Space Contained Fat Dissolved Out During the Processing. B, Uninflamed Chalazion. C, Acutely Inflamed Lesion. D, Conjunctival Granuloma. E, Marginal Chalazion. F, Conjunctival View of Chalazion Clamp in Place Before Incision and Curettage.

A, Courtesy of J. Harry and G. Misson, from Harry J, Misson G: Clinical ophthalmic pathology: principles of diseases of the eye and associated structures, Boston, 2001, Butterworth-Heinemann. F, from Nerad J et al: Rapid diagnosis in ophthalmology: oculoplastic and reconstructive surgery, St Louis, 2008, Mosby. From Bowling B: Kanski’s clinical ophthalmology, a systemic approach, ed 8, Philadelphia, 2016, Elsevier.

Etiology

Chalazia appear as small, red, rubbery nodules that are caused by local inflammation and obstruction of the sebaceous glands of the eyelids.1 Obstruction of the sebaceous glands results in lipid buildup and stasis. The lipid breakdown byproducts incite localized inflammation, which then recruits white blood cells to the area.

Diagnosis

Differential Diagnosis4

  • Hordeolum (stye)
  • Blepharitis
  • Papilloma
  • Xanthelasma
  • Dacryocystitis
  • Molluscum contagiosum
  • Leishmaniasis
  • Periorbital/orbital cellulitis
  • Abscess

Recurrent or persistent lesions:

  • Basal cell carcinoma
  • Sebaceous cell carcinoma
  • Meibomian gland carcinoma
  • Merkel cell carcinoma
Workup

Diagnosis is based on symptoms, clinical presentation, and physical exam findings. Testing is largely used to rule out other diagnoses. If question of alternative diagnosis, such as malignancy, biopsy is necessary as well as ophthalmologic consultation.

Laboratory Tests

None necessary for chalazion

Imaging Studies

None

Treatment

Disposition

Excellent patient prognosis. A small chalazion can be discharged home with instructions for conservative management.5 Large, recurrent, or persistent lesions may require an ophthalmology referral.

Referral

If not resolved within 1 mo, ophthalmologic consultation is warranted.

Invasive therapies, such as incision or steroid injections, may be considered first line for chalazia that have been present for longer than 2 mo, as these are less likely to resolve with warm compresses or other conservative treatments.

Pearls & Considerations

Comments

Frequently, a chalazion is confused with a hordeolum (stye). Chalazia are inflammatory lesions, not infectious, that usually develop slowly in the upper eyelid and tend to be painless. Hordeola are infected oil glands that tend to present at the lid margin with pain. However, some hordeola may transform into chalazia once inflammation has resolved.

Prevention

No specific prevention other than normal facial washing and hygiene.

Related Content

Stye (Hordeolum) (Related Key Topic)

Blepharitis (Related Key Topic)

Molluscum Contagiosum (Related Key Topic)

Related Content

  1. Carlisle R.T., Digiovanni J. : Differential diagnosis of the swollen red eyelidAm Fam Physician. ;92(2):106-112, 2015.
  2. Mégarbane B., Tadayoni R. : Cluster of chalazia in nurses using eye protection while caring for critically ill patients with COVID-19 in intensive careOccup Environ Med. ;77:584-585, 2020.
  3. Jordan G.A., Beier K. : Chalazion. [Updated 2020 Aug 8]. In StatPearls [Internet], Treasure Island, FL StatPearls Publishing, 2020.http://www.ncbi.nlm.nih.gov/books/NBK499889/
  4. Görsch I. : Chalazion-diagnosis and therapyMMW Fortschr Med. ;158(12):52-55, 2016.
  5. Wu A.Y. : Conservative therapy for chalazia: is it really effective?Acta Ophthalmol. ;96(4):e503-e509, 2018.
  6. Silkiss : Increased incidence of chalazion associated with face mask wear during the COVID-19 pandemicAm J Ophthalmol Case Rep. ;22, 2021.http://www.sciencedirect.com/science/article/pii/S2451993621000232?via%3Dihub